Tomris Erbaş

3.9k total citations
106 papers, 2.6k citations indexed

About

Tomris Erbaş is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tomris Erbaş has authored 106 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Physiology and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tomris Erbaş's work include Pituitary Gland Disorders and Treatments (37 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Heart Rate Variability and Autonomic Control (10 papers). Tomris Erbaş is often cited by papers focused on Pituitary Gland Disorders and Treatments (37 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Heart Rate Variability and Autonomic Control (10 papers). Tomris Erbaş collaborates with scholars based in Türkiye, United States and United Kingdom. Tomris Erbaş's co-authors include Aaron I. Vinik, Gary L. Pittenger, Tae Sun Park, Roger D. Nolan, Selçuk Dağdelen, Carolina Casellini, A Vinik, Roy Freeman, Belkıs Erbaş and Sema Akalın and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Tomris Erbaş

100 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomris Erbaş Türkiye 25 1.1k 887 581 573 268 106 2.6k
Joop D. Lefrandt Netherlands 30 765 0.7× 711 0.8× 299 0.5× 476 0.8× 235 0.9× 87 2.8k
Barbara H. Braffett United States 27 1.3k 1.2× 391 0.4× 458 0.8× 469 0.8× 122 0.5× 93 2.5k
Johannes Pleiner Austria 28 457 0.4× 566 0.6× 546 0.9× 677 1.2× 482 1.8× 56 2.5k
Per Løgstrup Poulsen Denmark 29 886 0.8× 1.1k 1.2× 325 0.6× 508 0.9× 213 0.8× 127 2.6k
Gary L. Pittenger United States 25 951 0.9× 500 0.6× 819 1.4× 1.3k 2.3× 309 1.2× 52 3.2k
J. E. Tooke United Kingdom 26 842 0.8× 619 0.7× 799 1.4× 562 1.0× 203 0.8× 66 2.2k
Karsten Müssig Germany 30 1.0k 0.9× 295 0.3× 731 1.3× 599 1.0× 641 2.4× 202 2.9k
Bert Bravenboer Netherlands 33 755 0.7× 271 0.3× 732 1.3× 504 0.9× 637 2.4× 107 3.4k
Krzysztof Strojek Poland 25 1.3k 1.2× 382 0.4× 502 0.9× 454 0.8× 135 0.5× 99 2.4k
Tatsuya Maruhashi Japan 30 597 0.5× 1.4k 1.5× 340 0.6× 738 1.3× 282 1.1× 146 3.1k

Countries citing papers authored by Tomris Erbaş

Since Specialization
Citations

This map shows the geographic impact of Tomris Erbaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomris Erbaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomris Erbaş more than expected).

Fields of papers citing papers by Tomris Erbaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomris Erbaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomris Erbaş. The network helps show where Tomris Erbaş may publish in the future.

Co-authorship network of co-authors of Tomris Erbaş

This figure shows the co-authorship network connecting the top 25 collaborators of Tomris Erbaş. A scholar is included among the top collaborators of Tomris Erbaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomris Erbaş. Tomris Erbaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Şendur, Süleyman Nahit, Büşra Aydın, İncilay Lay, et al.. (2022). Reduced irisin levels in patients with acromegaly. Hormone Molecular Biology and Clinical Investigation. 43(3). 251–261. 3 indexed citations
3.
Şendur, Süleyman Nahit, et al.. (2022). Giant growth hormone-secreting pituitary adenomas from the endocrinologist’s perspective. Endocrine. 79(3). 545–553. 6 indexed citations
4.
Şahin, Serdar, Nil Çomunoğlu, Hande Mefkure Özkaya, et al.. (2022). Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features. Pituitary. 25(3). 474–479. 6 indexed citations
5.
Şendur, Süleyman Nahit, et al.. (2022). Follow, consider, and catch: second primary tumors in acromegaly patients. Endocrine. 80(1). 160–173. 1 indexed citations
6.
Şendur, Süleyman Nahit, İncilay Lay, Basma Ellahi, et al.. (2022). Interaction between Dietary Fat Intake and Metabolic Genetic Risk Score on 25-Hydroxyvitamin D Concentrations in a Turkish Adult Population. Nutrients. 14(2). 382–382. 7 indexed citations
7.
Ünlütürk, Uğur, et al.. (2021). Clinical Course and Management of Pembrolizumab-Associated Isolated Adrenocorticotrophic Hormone Deficiency: A New Case and Literature Review. Immunotherapy. 13(14). 1157–1163. 5 indexed citations
8.
Şendur, Süleyman Nahit, Koray Ergünay, Annika Brinkmann, et al.. (2020). Probable alterations in fecal bacterial microbiota by somatostatin receptor analogs in acromegaly. Turkish Journal of Biochemistry. 45(6). 695–700. 1 indexed citations
9.
Keçeli, Hüseyin Gencay, et al.. (2019). The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients. Endocrine. 66(3). 622–633. 8 indexed citations
10.
Akalın, Sema, Murat Aydın, Mustafa Kemal Balcı, et al.. (2018). Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations. Endocrinology research and practice.. 22(3). 183–197.
11.
Erbaş, Tomris, Neşe Çınar, Selçuk Dağdelen, et al.. (2017). Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients. Pituitary. 20(5). 569–577. 6 indexed citations
12.
Aydın, Kadriye, et al.. (2015). Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly. Experimental and Clinical Endocrinology & Diabetes. 124(3). 198–202. 17 indexed citations
13.
Balcı, Serdar, Arzu Sağlam, Hakan Oruçkaptan, Tomris Erbaş, & Figen Söylemezoğlu. (2014). Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component. Pituitary. 18(1). 23–30. 17 indexed citations
14.
Akalın, Sema, Mustafa Araz, Mustafa Kemal Balcı, et al.. (2011). Biphasic Insulin Analogues in Type 2 Diabetes: Expert Panel Recommendations. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Özdemır, Didem, Selçuk Dağdelen, & Tomris Erbaş. (2011). Systemic Mastocytosis. The American Journal of the Medical Sciences. 342(5). 409–415. 8 indexed citations
16.
Vinik, Aaron I. & Tomris Erbaş. (2006). Cardiovascular autonomic neuropathy: Diagnosis and management. Current Diabetes Reports. 6(6). 424–430. 33 indexed citations
17.
Erbaş, Tomris. (2003). Metabolic syndrome. Acta Diabetologica. 40(0). s401–s404. 3 indexed citations
18.
Vinik, Aaron I., Tomris Erbaş, Tae Sun Park, Roger D. Nolan, & Gary L. Pittenger. (2001). Platelet Dysfunction in Type 2 Diabetes. Diabetes Care. 24(8). 1476–1485. 496 indexed citations
19.
Erbaş, Tomris, Aydan Usman, Belkıs Erbaş, et al.. (1993). Short-term effects of somatostatin analogue (SMS 201–995) on left ventricular function in healthy persons: A scintigraphic study. Journal of Endocrinological Investigation. 16(11). 857–861. 9 indexed citations
20.
Erbaş, Tomris, Belkıs Erbaş, Aydan Usman, & C F Bekdik. (1992). Assessment of Left Ventricular Dysfunction in Acromegalic Patients Using Radionuclide Ventriculography Parameters. Cardiology. 80(3-4). 172–179. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joop D. Lefrandt Breakdown of academic impact, for papers by Barbara H. Braffett Breakdown of academic impact, for papers by Johannes Pleiner Breakdown of academic impact, for papers by Per Løgstrup Poulsen Breakdown of academic impact, for papers by Gary L. Pittenger Breakdown of academic impact, for papers by J. E. Tooke Breakdown of academic impact, for papers by Karsten Müssig Breakdown of academic impact, for papers by Bert Bravenboer Breakdown of academic impact, for papers by Krzysztof Strojek Breakdown of academic impact, for papers by Tatsuya Maruhashi
Rankless by CCL
2026